# Interest of EMDR Schizophrenic Disorders

> **NCT05164289** · — · TERMINATED · sponsor: **Hôpital NOVO** · enrollment: 6 (actual)

## Conditions studied

- Schizophrenic Disorders

## Interventions

- **OTHER:** Control group
- **OTHER:** EMDR group

## Key facts

- **NCT ID:** NCT05164289
- **Lead sponsor:** Hôpital NOVO
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-10
- **Primary completion:** 2022-04-27
- **Final completion:** 2022-04-27
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** No patients included in the control group and inclusion rate too low.
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05164289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05164289, "Interest of EMDR Schizophrenic Disorders". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05164289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*